Cargando…
The impact of secondary hyperparathyroidism on the efficacy of antiresorptive therapy
BACKGROUND: The aim of the present study was to assess whether the efficacy of bisphosphonate treatment is influenced by PTH levels measured in newly diagnosed osteoporotic patients and to identify the threshold value, beyond which PTH level negatively influences therapeutic efficacy. METHODS: One h...
Autores principales: | Kincse, Gyöngyvér, Varga, József, Somogyi, Péter, Szodoray, Péter, Surányi, Péter, Gaál, János |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529113/ https://www.ncbi.nlm.nih.gov/pubmed/23227959 http://dx.doi.org/10.1186/1471-2474-13-244 |
Ejemplares similares
-
Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis
por: Rajput, Swati, et al.
Publicado: (2023) -
New Antiresorptive Therapies for Postmenopausal Osteoporosis
por: Choi, Hee-Jeong
Publicado: (2015) -
Diabetes Mellitus and the Benefit of Antiresorptive Therapy on Fracture Risk
por: Eastell, Richard, et al.
Publicado: (2022) -
Vitamin D deficiency in undifferentiated connective tissue disease
por: Zold, Eva, et al.
Publicado: (2008) -
The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in Men
por: Schwarz, Peter, et al.
Publicado: (2011)